These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

252 related items for PubMed ID: 833281

  • 1. Mechanism of complement-mediated activation of human blood platelets in vitro: comparison of normal and paroxysmal nocturnal hemoglobinuria platelets.
    Dixon RH, Rosse WF.
    J Clin Invest; 1977 Feb; 59(2):360-8. PubMed ID: 833281
    [Abstract] [Full Text] [Related]

  • 2. Enhanced reactive lysis of paroxysmal nocturnal hemoglobinuria erythrocytes by C5b-9 does not involve increased C7 binding or cell-bound C3b.
    Rosenfeld SI, Jenkins DE, Leddy JP.
    J Immunol; 1985 Jan; 134(1):506-11. PubMed ID: 3964820
    [Abstract] [Full Text] [Related]

  • 3. Human platelet-initiated formation and uptake of the C5-9 complex of human complement.
    Zimmerman TS, Kolb WP.
    J Clin Invest; 1976 Jan; 57(1):203-11. PubMed ID: 812888
    [Abstract] [Full Text] [Related]

  • 4. Complement lysis of human erythrocytes. Differeing susceptibility of two types of paroxysmal nocturnal hemoglobinuria cells to C5b-9.
    Packman CH, Rosenfeld SI, Jenkins DE, Thiem PA, Leddy JP.
    J Clin Invest; 1979 Aug; 64(2):428-33. PubMed ID: 457861
    [Abstract] [Full Text] [Related]

  • 5. Paroxysmal nocturnal hemoglobinuria. Enhanced stimulation of platelets by the terminal complement components is related to the lack of C8bp in the membrane.
    Blaas P, Berger B, Weber S, Peter HH, Hänsch GM.
    J Immunol; 1988 May 01; 140(9):3045-51. PubMed ID: 3361126
    [Abstract] [Full Text] [Related]

  • 6. A platelet and granulocyte membrane defect in paroxysmal nocturnal hemoglobinuria: usefulness for the detection of platelet antibodies.
    Aster RH, Enright SE.
    J Clin Invest; 1969 Jul 01; 48(7):1199-210. PubMed ID: 5798625
    [Abstract] [Full Text] [Related]

  • 7. Interactions of the platelets in paroxysmal nocturnal hemoglobinuria with complement. Relationship to defects in the regulation of complement and to platelet survival in vivo.
    Devine DV, Siegel RS, Rosse WF.
    J Clin Invest; 1987 Jan 01; 79(1):131-7. PubMed ID: 2432087
    [Abstract] [Full Text] [Related]

  • 8. Normal function of CR1 on affected erythrocytes of patients with paroxysmal nocturnal hemoglobinuria.
    Roberts WN, Wilson JG, Wong W, Jenkins DE, Fearon DT, Austen KF, Nicholson-Weller A.
    J Immunol; 1985 Jan 01; 134(1):512-7. PubMed ID: 2578050
    [Abstract] [Full Text] [Related]

  • 9. The membrane abnormalities in paroxysmal nocturnal hemoglobinuria (PNH).
    Rosse WF, Adams JP.
    Prog Clin Biol Res; 1979 Jan 01; 30():457-61. PubMed ID: 531036
    [Abstract] [Full Text] [Related]

  • 10. Deficiency of the complement regulatory protein, "decay-accelerating factor," on membranes of granulocytes, monocytes, and platelets in paroxysmal nocturnal hemoglobinuria.
    Nicholson-Weller A, Spicer DB, Austen KF.
    N Engl J Med; 1985 Apr 25; 312(17):1091-7. PubMed ID: 3845321
    [Abstract] [Full Text] [Related]

  • 11. Erythrocyte membrane protein deficiencies in paroxysmal nocturnal hemoglobinuria.
    Schultz DR.
    Am J Med; 1989 Sep 25; 87(3N):22N-29N. PubMed ID: 2484793
    [Abstract] [Full Text] [Related]

  • 12. Glycosylphosphatidylinositol (GPI)-anchored membrane proteins in clinical pathophysiology of paroxysmal nocturnal hemoglobinuria (PNH).
    Shichishima T.
    Fukushima J Med Sci; 1995 Jun 25; 41(1):1-13. PubMed ID: 8606038
    [Abstract] [Full Text] [Related]

  • 13. Disease-associated loss of erythrocyte complement receptors (CR1, C3b receptors) in patients with systemic lupus erythematosus and other diseases involving autoantibodies and/or complement activation.
    Ross GD, Yount WJ, Walport MJ, Winfield JB, Parker CJ, Fuller CR, Taylor RP, Myones BL, Lachmann PJ.
    J Immunol; 1985 Sep 25; 135(3):2005-14. PubMed ID: 4020137
    [Abstract] [Full Text] [Related]

  • 14. Alternate complement pathway induction of aggregation and release of 5-hydroxytryptamine and adenosine diphosphate by rabbit platelets.
    Marney SR, Colley DG, Des Prez RM.
    J Immunol; 1975 Feb 25; 114(2 Pt 1):696-703. PubMed ID: 804512
    [Abstract] [Full Text] [Related]

  • 15. Oxidative status of red blood cells, neutrophils, and platelets in paroxysmal nocturnal hemoglobinuria.
    Amer J, Zelig O, Fibach E.
    Exp Hematol; 2008 Apr 25; 36(4):369-77. PubMed ID: 18261835
    [Abstract] [Full Text] [Related]

  • 16. Complement activation in platelet concentrates is surface-dependent and modulated by the platelets.
    Gyongyossy-Issa MI, McLeod E, Devine DV.
    J Lab Clin Med; 1994 Jun 25; 123(6):859-68. PubMed ID: 8201264
    [Abstract] [Full Text] [Related]

  • 17. The dysfunction of platelets in paroxysmal nocturnal hemoglobinuria.
    Fu R, Meng Y, Wang Y, Liu H, Liu Y, Li L, Ding S, Wang G, Song J, Shao Z.
    Thromb Res; 2016 Dec 25; 148():50-55. PubMed ID: 27780113
    [Abstract] [Full Text] [Related]

  • 18. Characterization of the complement sensitivity of paroxysmal nocturnal hemoglobinuria erythrocytes.
    Parker CJ, Wiedmer T, Sims PJ, Rosse WF.
    J Clin Invest; 1985 Jun 25; 75(6):2074-84. PubMed ID: 4008653
    [Abstract] [Full Text] [Related]

  • 19. In vitro histamine and serotonin release by radiographic contrast media (RCM). Complement-dependent and -independent release reaction and changes in ultrastructure of human blood cells.
    Ring J, Arroyave CM, Frizler MJ, Tan EM.
    Clin Exp Immunol; 1978 Apr 25; 32(1):105-18. PubMed ID: 78780
    [Abstract] [Full Text] [Related]

  • 20. T-lymphocytes escape membrane defect in paroxysmal nocturnal haemoglobinuria.
    Cooper MR, Currie MS, Rustagi PK, Logue GL.
    Br J Haematol; 1983 Oct 25; 55(2):263-71. PubMed ID: 6604541
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.